PROPOFOL
Substance profile for UNII YI7VU623SF, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 4943Substance Identity#
- UNII
- YI7VU623SF
- Preferred term
- PROPOFOL
- Registry number
- 2078-54-8
- EC number
- 218-206-6
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C12H18O
Structure render from PubChem CID 4943Chemical And Database Identifiers#
- InChIKey
- OLBCVFGFOZPWHH-UHFFFAOYSA-N
- SMILES
- CC(C)C1=CC=CC(C(C)C)=C1O
- RxCUI
- 8782
- PubChem
- 4943
- NCIt
- C29384
- INN ID
- 5073
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | DIPRIVAN (PROPOFOL) INJECTION, EMULSION [FRESENIUS KABI USA, LLC] | 6 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | DIPRIVAN (PROPOFOL) INJECTION, EMULSION [FRESENIUS KABI USA, LLC] | 6 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | PROPOFOL INJECTION, EMULSION [HOSPIRA, INC.] | 6 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | PROPOFOL INJECTION, EMULSION [HOSPIRA, INC.] | 6 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | PROPOFLO (PROPOFOL) INJECTION, EMULSION [ABBOTT LABORATORIES] | 4 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | PROPOFLO (PROPOFOL) INJECTION, EMULSION [ABBOTT LABORATORIES] | 4 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | PROPOFLO 28 (PROPOFOL) INJECTION, EMULSION [ABBOTT LABORATORIES] | 4 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | PROPOFLO 28 (PROPOFOL) INJECTION, EMULSION [ABBOTT LABORATORIES] | 4 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | PROPOFOL INJECTION, EMULSION [TEVA PARENTERAL MEDICINES, INC.] | 4 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | PROPOFOL INJECTION, EMULSION [TEVA PARENTERAL MEDICINES, INC.] | 4 | |
| Propofol | ACTIVE MOIETY | YI7VU623SF | DIPRIVAN (PROPOFOL) INJECTION, EMULSION [ASTRAZENECA PHARMACEUTICALS LP] | 3 | |
| Propofol | ACTIVE INGREDIENT | YI7VU623SF | DIPRIVAN (PROPOFOL) INJECTION, EMULSION [ASTRAZENECA PHARMACEUTICALS LP] | 3 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | DIPRIVAN (PROPOFOL) INJECTION, EMULSION [FRESENIUS KABI USA, LLC] | 3 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | DIPRIVAN (PROPOFOL) INJECTION, EMULSION [FRESENIUS KABI USA, LLC] | 3 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | DIPRIVAN (PROPOFOL) INJECTION, EMULSION [FRESENIUS KABI USA, LLC] | 3 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | DIPRIVAN (PROPOFOL) INJECTION, EMULSION [FRESENIUS KABI USA, LLC] | 3 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | PROPOFOL INJECTION, EMULSION [APP PHARMACEUTICALS, LLC] | 3 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | PROPOFOL INJECTION, EMULSION [APP PHARMACEUTICALS, LLC] | 3 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | PROPOFOL INJECTION, EMULSION [APP PHARMACEUTICALS, LLC] | 3 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | PROPOFOL INJECTION, EMULSION [APP PHARMACEUTICALS, LLC] | 3 | |
| propofol | ACTIVE MOIETY | YI7VU623SF | PROPOFOL INJECTION, EMULSION [SAGENT PHARMACEUTICALS] | 3 | |
| propofol | ACTIVE INGREDIENT | YI7VU623SF | PROPOFOL INJECTION, EMULSION [SAGENT PHARMACEUTICALS] | 3 | |
| Propofol | ACTIVE MOIETY | YI7VU623SF | DIPRIVAN INJECTION, EMULSION [GENERAL INJECTABLES & VACCINES, INC] | 2 | |
| Propofol | ACTIVE INGREDIENT | YI7VU623SF | DIPRIVAN INJECTION, EMULSION [GENERAL INJECTABLES & VACCINES, INC] | 2 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | PROPOFOL INJECTION, EMULSION [APP PHARMACEUTICALS, LLC] | 2 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | PROPOFOL INJECTION, EMULSION [APP PHARMACEUTICALS, LLC] | 2 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | PROPOFOL INJECTION, EMULSION [FRESENIUS KABI USA, LLC] | 2 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | PROPOFOL INJECTION, EMULSION [FRESENIUS KABI USA, LLC] | 2 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | RAPINOVET (PROPOFOL) INJECTION, EMULSION [BAYER HEALTHCARE LLC] | 2 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | RAPINOVET (PROPOFOL) INJECTION, EMULSION [BAYER HEALTHCARE LLC] | 2 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | DIPRIVAN (PROPOFOL) INJECTION, EMULSION [FRESENIUS KABI USA, LLC] | 1 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | DIPRIVAN (PROPOFOL) INJECTION, EMULSION [FRESENIUS KABI USA, LLC] | 1 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | PROPOFLO (PROPOFOL) INJECTION, EMULSION [ZOETIS INC.] | 1 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | PROPOFLO (PROPOFOL) INJECTION, EMULSION [ZOETIS INC.] | 1 | |
| PROPOFOL | ACTIVE MOIETY | YI7VU623SF | PROPOFOL INJECTION, EMULSION [GENERAL INJECTABLES AND VACCINES, INC] | 1 | |
| PROPOFOL | ACTIVE INGREDIENT | YI7VU623SF | PROPOFOL INJECTION, EMULSION [GENERAL INJECTABLES AND VACCINES, INC] | 1 | |